MedPath

青岛冠龙生物制药有限公司

Ownership
-
Established
1997-05-28
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

67

NMPA:67

Drug Approvals

Urokinase for Injection

Product Name
注射用尿激酶
Approval Number
国药准字H20184169
Approval Date
Dec 15, 2023
NMPA

Urokinase for Injection

Product Name
注射用尿激酶
Approval Number
国药准字H20184168
Approval Date
Dec 15, 2023
NMPA

Chorionic Gonadotrophin for Injection

Product Name
注射用绒促性素
Approval Number
国药准字H20184170
Approval Date
Dec 12, 2023
NMPA

Chorionic Gonadotrophin for Injection

Product Name
注射用绒促性素
Approval Number
国药准字H20184171
Approval Date
Dec 12, 2023
NMPA

Chorionic Gonadotrophin for Injection

Product Name
注射用绒促性素
Approval Number
国药准字H20184172
Approval Date
Dec 12, 2023
NMPA

Calcium Lactate Tablets

Product Name
乳酸钙片
Approval Number
国药准字H20174113
Approval Date
Aug 17, 2022
NMPA

Calcium Lactate Tablets

Product Name
乳酸钙片
Approval Number
国药准字H20174114
Approval Date
Aug 17, 2022
NMPA

Chorionic Gonadotrophin for Injection

Product Name
注射用绒促性素
Approval Number
国药准字H32024604
Approval Date
Aug 15, 2014
NMPA

Heparin Sodium Injection

Product Name
肝素钠注射液
Approval Number
国药准字H32021979
Approval Date
Aug 15, 2014
NMPA

Defibrase for Injection

Product Name
注射用降纤酶
Approval Number
国药准字H10983229
Approval Date
Aug 15, 2014
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.